OCUL – Ocular Therapeutix, Inc.
Float Short %
5.67
Margin Of Safety %
Put/Call OI Ratio
0.47
EPS Next Q Diff
-1.84
EPS Last/This Y
-0.21
EPS This/Next Y
-0.05
Price
11.49
Target Price
24.62
Analyst Recom
1.08
Performance Q
-0.17
Relative Volume
0.82
Beta
0.9
Ticker: OCUL
of 1
| Date | Symbol | Latest | P/C OI | P/C Vol | Total OI |
|---|---|---|---|---|---|
| 2025-12-09 | OCUL | 15.94 | 0.40 | 0.69 | 83577 |
| 2025-12-10 | OCUL | 15.4 | 0.40 | 1.98 | 84310 |
| 2025-12-11 | OCUL | 14.66 | 0.45 | 0.40 | 89284 |
| 2025-12-12 | OCUL | 14.57 | 0.45 | 1.52 | 90955 |
| 2025-12-15 | OCUL | 14.16 | 0.43 | 0.67 | 90369 |
| 2025-12-16 | OCUL | 14.39 | 0.43 | 1.25 | 90518 |
| 2025-12-17 | OCUL | 13.72 | 0.44 | 3.00 | 92006 |
| 2025-12-18 | OCUL | 12.98 | 0.47 | 0.08 | 95384 |
| 2025-12-19 | OCUL | 12.55 | 0.46 | 0.12 | 96767 |
| 2025-12-22 | OCUL | 13 | 0.47 | 0.34 | 87026 |
| 2025-12-23 | OCUL | 12.75 | 0.48 | 0.05 | 88076 |
| 2025-12-26 | OCUL | 12.56 | 0.46 | 0.01 | 91183 |
| 2025-12-29 | OCUL | 12.29 | 0.46 | 0.32 | 91062 |
| 2025-12-30 | OCUL | 12.2 | 0.46 | 0.01 | 92038 |
| 2025-12-31 | OCUL | 12.13 | 0.46 | 0.05 | 92400 |
| 2026-01-02 | OCUL | 11.82 | 0.47 | 0.39 | 93008 |
| 2026-01-05 | OCUL | 11.54 | 0.47 | 0.13 | 93577 |
| 2026-01-06 | OCUL | 11.25 | 0.47 | 0.37 | 93768 |
| 2026-01-07 | OCUL | 11.49 | 0.47 | 1.01 | 94780 |
| Date | Symbol | Latest | P/C OI | P/C Vol | Total OI |
Current Page1 of 1
of 1
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
|---|---|---|---|---|---|
| 2025-12-09 | OCUL | 15.95 | -16.1 | - | -1.42 |
| 2025-12-10 | OCUL | 15.40 | -16.1 | - | -1.42 |
| 2025-12-11 | OCUL | 14.66 | -16.1 | - | -1.42 |
| 2025-12-12 | OCUL | 14.56 | -16.1 | - | -1.42 |
| 2025-12-15 | OCUL | 14.17 | -16.1 | - | -1.42 |
| 2025-12-16 | OCUL | 14.17 | -16.1 | - | -1.43 |
| 2025-12-17 | OCUL | 13.73 | -16.1 | - | -1.43 |
| 2025-12-18 | OCUL | 12.98 | -16.1 | - | -1.43 |
| 2025-12-19 | OCUL | 12.55 | -16.1 | - | -1.43 |
| 2025-12-22 | OCUL | 12.94 | -16.1 | - | -1.43 |
| 2025-12-23 | OCUL | 12.73 | -16.1 | - | -1.43 |
| 2025-12-26 | OCUL | 12.57 | -16.1 | - | -1.43 |
| 2025-12-29 | OCUL | 12.30 | -16.1 | - | -1.43 |
| 2025-12-30 | OCUL | 12.20 | -16.1 | - | -1.43 |
| 2025-12-31 | OCUL | 12.13 | -16.1 | - | -1.43 |
| 2026-01-02 | OCUL | 11.83 | -16.1 | - | -1.43 |
| 2026-01-05 | OCUL | 11.54 | -16.1 | - | -1.43 |
| 2026-01-06 | OCUL | 11.25 | -16.1 | - | -1.43 |
| 2026-01-07 | OCUL | 11.49 | -16.1 | - | -1.43 |
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
Current Page1 of 1
of 1
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
|---|---|---|---|---|
| 2025-12-09 | OCUL | -0.44 | 18.54 | 7.05 |
| 2025-12-10 | OCUL | -0.44 | 18.54 | 6.23 |
| 2025-12-11 | OCUL | -0.44 | 18.54 | 6.22 |
| 2025-12-12 | OCUL | -0.44 | 18.54 | 6.22 |
| 2025-12-15 | OCUL | -0.44 | 19.12 | 6.22 |
| 2025-12-16 | OCUL | -0.44 | 19.12 | 6.22 |
| 2025-12-17 | OCUL | -0.44 | 19.12 | 6.22 |
| 2025-12-18 | OCUL | -0.44 | 19.12 | 6.22 |
| 2025-12-19 | OCUL | -0.44 | 19.12 | 6.22 |
| 2025-12-22 | OCUL | -0.44 | 19.12 | 6.22 |
| 2025-12-23 | OCUL | -0.44 | 19.12 | 6.22 |
| 2025-12-26 | OCUL | -0.44 | 19.12 | 5.67 |
| 2025-12-29 | OCUL | -0.44 | 19.13 | 5.67 |
| 2025-12-30 | OCUL | -0.44 | 19.13 | 5.67 |
| 2025-12-31 | OCUL | -0.44 | 19.13 | 5.67 |
| 2026-01-02 | OCUL | -0.44 | 19.13 | 5.67 |
| 2026-01-05 | OCUL | -0.44 | 19.15 | 5.67 |
| 2026-01-06 | OCUL | -0.44 | 19.15 | 5.67 |
| 2026-01-07 | OCUL | -0.44 | 19.15 | 5.67 |
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
Current Page1 of 1
Last Quarter Act. EPS
1.5
Avg. EPS Est. Current Quarter
-0.34
Avg. EPS Est. Next Quarter
-0.34
Insider Transactions
-0.44
Institutional Transactions
19.15
Beta
0.9
Average Sales Estimate Current Quarter
16
Average Sales Estimate Next Quarter
14
Fair Value
Quality Score
37
Growth Score
37
Sentiment Score
45
Actual DrawDown %
51.5
Max Drawdown 5-Year %
-90.6
Target Price
24.62
P/E
Forward P/E
PEG
P/S
43.92
P/B
7.79
P/Free Cash Flow
EPS
-1.44
Average EPS Est. Cur. Y
-1.43
EPS Next Y. (Est.)
-1.48
Target Price Estimates Raised
Target Price Estimates Lowered
Profit Margin
-447.58
Relative Volume
0.82
Return on Equity vs Sector %
-123.8
Return on Equity vs Industry %
-108.6
EPS 1 7Days Diff
EPS 1 30Days Diff
-0.01
EBIT Estimation
Ocular Therapeutix, Inc.Sector: Healthcare
Industry: Biotechnology
Employees: 274
Ocular Therapeutix, Inc., a biopharmaceutical company, engages in the development and commercialization of therapies for retinal diseases and other eye conditions using its bioresorbable hydrogel-based formulation technology in the United States. The company markets DEXTENZA, a dexamethasone ophthalmic insert to treat post-surgical ocular inflammation and pain following ophthalmic surgery, as well as allergic conjunctivitis. It is also developing AXPAXLI, an axitinib intravitreal hydrogel that is in phase 3 clinical trials for the treatment of wet age-related macular degeneration and in Phase 1 clinical trials for the treatment of non-proliferative diabetic retinopathy; PAXTRAVA, a travoprost intracameral hydrogel, which is in phase 2 clinical trials for the treatment of open-angle glaucoma or ocular hypertension. The company has a license agreement and collaboration with AffaMed Therapeutics Limited for the development and commercialization of DEXTENZA and PAXTRAVA. Ocular Therapeutix, Inc. was incorporated in 2006 and is headquartered in Bedford, Massachusetts.
stock quote shares OCUL – Ocular Therapeutix, Inc. Stock Price stock today
news today OCUL – Ocular Therapeutix, Inc. stock forecast ,stock prediction 2023 2024 2025
marketwatch OCUL – Ocular Therapeutix, Inc. yahoo finance google finance
stock history OCUL – Ocular Therapeutix, Inc. invest stock market
stock prices OCUL premarket after hours
ticker OCUL fair value insiders trading